Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie: Dancing On Humira's Grave
10:00am, Wednesday, 19'th Jul 2023
AbbVie's flagship drug Humira is facing competition from biosimilars, but the company is expected to offset revenue losses in the segment with Skyrizi & Rinvoq. Two real growth drivers for AbbVie are
3 Dividend Stocks That Still Make Sense in 2023
07:31am, Monday, 17'th Jul 2023
It was hard to find big stock market winners in 2022. But dividend stocks were among the better performers.
FDL: Underperforming In 2023
10:51am, Thursday, 13'th Jul 2023
FDL: Underperforming In 2023
3 Biotech Stocks to Sell Before They Damage Your Portfolio
05:33pm, Wednesday, 12'th Jul 2023
There are several reasons that investors should be cautious about buying or holding biotech stocks at this point. First, the Street is generally bearish on the sector lately.
Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say
03:59pm, Wednesday, 12'th Jul 2023
The brisk pace of biopharmaceutical deal making seen in the first half of this year may only accelerate in the months ahead, even as regulators take a hard look at some of the bigger deals, analysts s
4 Dividend Aristocrat Buys For July And 6 To Watch
07:39pm, Tuesday, 11'th Jul 2023
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 67 Aristocrats, screened as of July 7, 2023, repre
The Ultimate Buffett-Style 5% Yielding Dividend Aristocrat Portfolio
07:15am, Tuesday, 11'th Jul 2023
The economic data is showing that a recession is almost certainly coming, but it now appears to be most likely to start in the first half of 2024. Impatience, and fear of missing out, have caused many
AbbVie's R&D Pipeline: Driving Long-Term Growth
10:51am, Monday, 10'th Jul 2023
AbbVie Inc. ( ABBV , Financial) is facing aggressive competition against its blockbuster Humira, which has put pressure on its stock. But with a robust research and development pipeline boasting over
3 No-Brainer Stocks You Can Buy Right Now
06:14am, Saturday, 08'th Jul 2023
Some investors are fearful about AbbVie right now, but it's better to be greedy with the stock. Pfizer offers a solid dividend and great growth prospects.
The 3 Best Dividend Stocks to Buy in July
11:41am, Friday, 07'th Jul 2023
Dividend stocks continue to be highly sought after, especially among investors who seek to generate income. Retirees appreciate the regular payments provided by stocks that offer dividends to their sh
Just How Hot Have These Tech Stocks Been?
10:41am, Friday, 07'th Jul 2023
Subscribers to Chart of the Week received this commentary on Sunday, July 2.
2 Struggling Dividend Growth Stocks That Could Make You Richer
09:45am, Friday, 07'th Jul 2023
AbbVie should survive the loss of exclusivity of its crown jewel, Humira. Amgen's struggles are real, but so is the company's ability to innovate.
Buy 5 High ROE Stocks as Market Rally Skids on ADP Jobs Data
09:23am, Friday, 07'th Jul 2023
Dillard's (DDS), Suzano (SUZ), Atkore (ATKR), Nexstar (NXST) and AbbVie (ABBV) are some of the stocks with high ROE to profit from as markets decline on better-than-expected ADP jobs data.
Why Dividend Stocks Should Be a Key Part of Your Retirement Plan
07:15am, Friday, 07'th Jul 2023
If you worry you won't have enough saved up by retirement, dividend stocks can help boost your income. Allocating part of your retirement savings to such equities can reduce depletion of your savings.
The 7 Best Long-Term Stocks to Buy in July
03:36pm, Thursday, 06'th Jul 2023
Investing features many similarities to the game of baseball, which helps drive the case for the best long-term stocks in July. Unlike the NFL where teams play only 17 regular-season games, in MLB, th
